Category:Experiments

0–9

• The gut microbiota in conventional and serrated precursors of colorectal cancer/Experiment 1
• Microbiomic differences in tumor and paired-normal tissue in head and neck squamous cell carcinomas/Experiment 1
• Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations/Experiment 1
• Gut microbiome alterations in patients with stage 4 hepatitis C/Experiment 1
• The lung microbiome in moderate and severe chronic obstructive pulmonary disease/Experiment 1
• Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease/Experiment 1
• Pyrosequencing study of fecal microflora of autistic and control children/Experiment 1
• Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults/Experiment 1
• A comprehensive analysis of breast cancer microbiota and host gene expression/Experiment 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
• Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions/Experiment 1
• Association of cervical microbial community with persistence, clearance and negativity of Human Papillomavirus in Korean women: a longitudinal study/Experiment 1
• The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia/Experiment 1
• The tongue microbiome in healthy subjects and patients with intra-oral halitosis/Experiment 1
• The Placental Microbiota Is Altered among Subjects with Gestational Diabetes Mellitus: A Pilot Study/Experiment 1
• Melatonin prevents obesity through modulation of gut microbiota in mice/Experiment 1
• Altered gut microbiota profile in patients with generalized anxiety disorder/Experiment 1
• High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice/Experiment 1
• Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study/Experiment 1
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota/Experiment 1
• 16S gut community of the Cameron County Hispanic Cohort/Experiment 1
• Analysis of Gut Microbiota in Patients with Parkinson's Disease/Experiment 1
• Gut microbiome alterations in Alzheimer's disease/Experiment 1
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function/Experiment 1
• Microbiome dynamics of human epidermis following skin barrier disruption/Experiment 1
• Intestinal Microbiota Is Influenced by Gender and Body Mass Index/Experiment 1
• Maternal omega-3 fatty acids regulate offspring obesity through persistent modulation of gut microbiota/Experiment 1
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
• Altered fecal microbiota composition in patients with major depressive disorder/Experiment 1
• High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients/Experiment 1
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome/Experiment 1
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests/Experiment 1
• Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing/Experiment 1
• A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode/Experiment 1
• Molecular analysis of oral microflora in patients with primary Sjögren's syndrome by using high-throughput sequencing/Experiment 1
• Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns/Experiment 1
• Dysbiosis signature of fecal microbiota in colorectal cancer patients/Experiment 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
• Understanding the microbial basis of body odor in pre-pubescent children and teenagers/Experiment 1
• Gut microbiome in ADHD and its relation to neural reward anticipation/Experiment 1
• Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response/Experiment 1
• Alterations of Gut Microbiota in Cholestatic Infants and Their Correlation With Hepatic Function/Experiment 1
• Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease/Experiment 1
• Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations/Experiment 1
• An intermittent hypercaloric diet alters gut microbiota, prefrontal cortical gene expression and social behaviours in rats/Experiment 1
• Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study/Experiment 1
• Diet, physical activity and screen time but not body mass index are associated with the gut microbiome of a diverse cohort of college students living in university housing: a cross-sectional study/Experiment 1
• Obesity Alters the Microbial Community Profile in Korean Adolescents/Experiment 1
• Characterization of the salivary microbiome in people with obesity/Experiment 1
• Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers/Experiment 1
• Gut microbiota in patients after surgical treatment for colorectal cancer/Experiment 1
• Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing/Experiment 1
• Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)/Experiment 1
• Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid/Experiment 1
• Gut microbiota composition is correlated to grid floor induced stress and behavior in the BALB/c mouse/Experiment 1
• Diversified microbiota of meconium is affected by maternal diabetes status/Experiment 1
• The microbiome of the oral mucosa in irritable bowel syndrome/Experiment 1
• The early infant gut microbiome varies in association with a maternal high-fat diet/Experiment 1
• Exposure to Titanium Dioxide Nanoparticles During Pregnancy Changed Maternal Gut Microbiota and Increased Blood Glucose of Rat/Experiment 1
• Association between blood microbiome and type 2 diabetes mellitus: A nested case-control study/Experiment 1
• Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy/Experiment 1
• Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease/Experiment 1
• Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section/Experiment 1
• Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing/Experiment 1
• Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis/Experiment 1
• Meconium microbiome associates with the development of neonatal jaundice/Experiment 1
• New evidences on the altered gut microbiota in autism spectrum disorders/Experiment 1
• A taxonomic signature of obesity in a large study of American adults/Experiment 1
• Body Mass Index Differences in the Gut Microbiota Are Gender Specific/Experiment 1
• Composition of gut microbiota in obese and normal-weight Mexican school-age children and its association with metabolic traits/Experiment 1
• Meconium microbiome analysis identifies bacteria correlated with premature birth/Experiment 1
• Analysis of gut microbiota profiles and microbe-disease associations in children with autism spectrum disorders in China/Experiment 1
• Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome/Experiment 1
• Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 1
• Disordered microbial communities in the upper respiratory tract of cigarette smokers/Experiment 1
• Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children/Experiment 1
• Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort/Experiment 1
• Chronic Early-life Stress in Rat Pups Alters Basal Corticosterone, Intestinal Permeability, and Fecal Microbiota at Weaning: Influence of Sex/Experiment 1
• Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption/Experiment 1
• Fecal microbiota imbalance in Mexican children with type 1 diabetes/Experiment 1
• Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters/Experiment 1
• Evolution in fecal bacterial/viral composition in infants of two central African countries (Gabon and Republic of the Congo) during their first month of life/Experiment 1
• Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 1
• Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study/Experiment 1
• Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects/Experiment 1
• Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease/Experiment 1
• Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function/Experiment 1
• Initial meconium microbiome in Chinese neonates delivered naturally or by cesarean section/Experiment 1
• Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease/Experiment 1
• Maternal influence on the fetal microbiome in a population-based study of the first-pass meconium/Experiment 1
• Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing/Experiment 1
• Gut microbiota and overweight in 3-year old children/Experiment 1
• Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population/Experiment 1
• Differential composition of gut microbiota among healthy volunteers, morbidly obese patients and post-bariatric surgery patients/Experiment 1
• Blood Microbiome Profile in CKD : A Pilot Study/Experiment 1
• Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention/Experiment 1
• Gut Microbiota in Patients with Different Metabolic Statuses: Moscow Study/Experiment 1
• Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii/Experiment 1
• The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes/Experiment 1
• Sex differences in gut microbiota in patients with major depressive disorder/Experiment 1
• Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder/Experiment 1
• The gut microbiome composition associates with bipolar disorder and illness severity/Experiment 1
• Gut microbiota composition in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives/Experiment 1
• The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology/Experiment 1
• Gut Dysbiosis in Patients with Anorexia Nervosa/Experiment 1
• Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints/Experiment 1
• Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia/Experiment 1
• Gut microbiota profiles in treatment-naïve children with attention deficit hyperactivity disorder/Experiment 1
• Reduced microbiome alpha diversity in young patients with ADHD/Experiment 1
• Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder/Experiment 1
• Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder/Experiment 1
• Similarly in depression, nuances of gut microbiota: Evidences from a shotgun metagenomics sequencing study on major depressive disorder versus bipolar disorder with current major depressive episode patients/Experiment 1
• Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study/Experiment 1
• Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients/Experiment 1
• The Perturbation of Infant Gut Microbiota Caused by Cesarean Delivery Is Partially Restored by Exclusive Breastfeeding/Experiment 1
• Gut microbiota varies by opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden of chronic disease/Experiment 1
• Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels/Experiment 1
• Subgingival Microbiome of Gingivitis in Chinese Undergraduates/Experiment 1
• Microbial dysbiosis is associated with human breast cancer/Experiment 1
• High fat diet alters gut microbiota but not spatial working memory in early middle-aged Sprague Dawley rats/Experiment 1
• The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study/Experiment 1
• Analysis of oral microbiota in Japanese oral cancer patients using 16S rRNA sequencing/Experiment 1
• Changes in the salivary microbiota of oral leukoplakia and oral cancer/Experiment 1
• Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption/Experiment 1
• Mucosal microbiome dysbiosis in gastric carcinogenesis/Experiment 1
• Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls/Experiment 1
• Influence of food consumption patterns and Galician lifestyle on human gut microbiota/Experiment 1
• Daily Consumption of Orange Juice from Citrus sinensis L. Osbeck cv. Cara Cara and cv. Bahia Differently Affects Gut Microbiota Profiling as Unveiled by an Integrated Meta-Omics Approach/Experiment 1
• Impact of Agaricus bisporus Mushroom Consumption on Gut Health Markers in Healthy Adults/Experiment 1
• Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial/Experiment 1
• Microbial enterotypes, inferred by the prevotella-to-bacteroides ratio, remained stable during a 6-month randomized controlled diet intervention with the new nordic diet/Experiment 1
• Linking long-term dietary patterns with gut microbial enterotypes/Experiment 1
• Microbiome Responses to an Uncontrolled Short-Term Diet Intervention in the Frame of the Citizen Science Project/Experiment 1
• Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway/Experiment 1
• Dysbiosis of the Gut Microbiome in Lung Cancer/Experiment 1
• Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer/Experiment 1
• Alterations of the human gut microbiome in multiple sclerosis/Experiment 1
• Establishment of vaginal microbiota composition in early pregnancy and its association with subsequent preterm prelabor rupture of the fetal membranes/Experiment 1
• 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, human papilloma virus infection and surgical treatment/Experiment 1
• The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis/Experiment 1
• Air pollution during the winter period and respiratory tract microbial imbalance in a healthy young population in Northeastern China/Experiment 1
• The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects/Experiment 1
• Variations in oral microbiota associated with oral cancer/Experiment 1
• Microbiota in the Throat and Risk Factors for Laryngeal Carcinoma/Experiment 1
• Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study/Experiment 1
• The gut microbiome of Mexican children affected by obesity/Experiment 1
• Variations in Oral Microbiota Composition Are Associated With a Risk of Throat Cancer/Experiment 1
• Breast cancer in postmenopausal women is associated with an altered gut metagenome/Experiment 1
• Altered diversity and composition of the gut microbiome in patients with cervical cancer/Experiment 1
• The Microbiome of Prostate Fluid Is Associated With Prostate Cancer/Experiment 1
• Altered intestinal microbiota associated with colorectal cancer/Experiment 1
• Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers/Experiment 1
• Intestinal Microbiota Is Altered in Patients with Gastric Cancer from Shanxi Province, China/Experiment 1
• Oral Microbiota and Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Area of China/Experiment 1
• Alterations of fecal bacterial communities in patients with lung cancer/Experiment 1
• Subgingival Microbial Changes During the First 3 Months of Fixed Appliance Treatment in Female Adult Patients/Experiment 1
• The Performance of an Oral Microbiome Biomarker Panel in Predicting Oral Cavity and Oropharyngeal Cancers/Experiment 1
• Salivary Microbial Dysbiosis is Associated with Systemic Inflammatory Markers and Predicted Oral Metabolites in Non-Small Cell Lung Cancer Patients/Experiment 1
• Dysbiosis of the Gut Microbiome is associated with Tumor Biomarkers in Lung Cancer/Experiment 1
• The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study/Experiment 1
• Variations of Tongue Coating Microbiota in Patients with Gastric Cancer/Experiment 1
• Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease/Experiment 1
• Altered gut microbiota and microbial biomarkers associated with chronic kidney disease/Experiment 1
• Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging/Experiment 1
• Altered oral microbiota in chronic hepatitis B patients with different tongue coatings/Experiment 1
• Microbial biomarkers of common tongue coatings in patients with gastric cancer/Experiment 1
• Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects/Experiment 1
• Characteristics of the Salivary Microbiota in Patients With Various Digestive Tract Cancers/Experiment 1
• Microbiomic differences at cancer-prone oral mucosa sites with marijuana usage/Experiment 1
• Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China/Experiment 1
• Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues/Experiment 1
• Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study/Experiment 1
• Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation/Experiment 1
• Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention/Experiment 1
• Regulatory T Cells and Plasmacytoid Dendritic Cells Within the Tumor Microenvironment in Gastric Cancer Are Correlated With Gastric Microbiota Dysbiosis: A Preliminary Study/Experiment 1
• Oral Microbiome in Patients with Oesophageal Squamous Cell Carcinoma/Experiment 1
• Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota/Experiment 1
• Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components/Experiment 1
• Relationship between acetaldehyde concentration in mouth air and characteristics of microbiota of tongue dorsum in Japanese healthy adults: a cross-sectional study/Experiment 1
• Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease/Experiment 1
• A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis/Experiment 1
• Gut microbiota shifts in patients with gastric cancer in perioperative period/Experiment 1
• Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women/Experiment 1
• Prospective observational study of vaginal microbiota pre- and post-rescue cervical cerclage/Experiment 1
• Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients/Experiment 1
• Environmental toxicants in breast milk of Norwegian mothers and gut bacteria composition and metabolites in their infants at 1 month/Experiment 1
• Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production/Experiment 1
• Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome/Experiment 1
• Differences in gastric mucosal microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric cancer using pyrosequencing methods/Experiment 1
• The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients/Experiment 1
• Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project/Experiment 1
• Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children/Experiment 1
• Lower airway microbiota and mycobiota in children with severe asthma/Experiment 1
• Oral microbiota dysbiosis and its association with Henoch-Schönlein Purpura in children/Experiment 1
• The differential distribution of bacteria between cancerous and noncancerous ovarian tissues in situ/Experiment 1
• Postmenopause as a key factor in the composition of the Endometrial Cancer Microbiome (ECbiome)/Experiment 1
• Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia/Experiment 1